Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience
- PMID: 16697803
- DOI: 10.1016/S0022-5347(06)00322-3
Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience
Abstract
Purpose: Partial cystectomy is a surgical option for select patients diagnosed with urothelial carcinoma. We review our experience with partial cystectomy for muscle invasive urothelial carcinoma to assess local control and survival rates.
Material and methods: From 1982 to 2003 a total of 37 patients with muscle invasive urothelial carcinoma underwent partial cystectomy with curative intent. Reviewed data included history of superficial tumors, presence of variant histology, tumor location, clinical stage, pathological stage, presence of carcinoma in situ, adjuvant therapy and disease status.
Results: The 5-year overall, disease specific and recurrence-free survival rates were 67%, 87% and 39%, respectively. Mean followup was 72.6 months (range 6 to 217). Of the 37 patients 19 (51%) did not have tumor recurrence, 9 (24%) had superficial recurrence in the bladder that was treated successfully and 9 (24%) had recurrence with advanced disease. A total of 24 patients (65%) had an intact bladder with no evidence of disease after a median of 53 months. There were 6 patients (16%) who died of bladder cancer, 3 of whom died of late recurrence of muscle invasive cancer (41, 44 and 138 months after partial cystectomy). On multivariate analysis higher pathological stage (HR 3.4, p = 0.04) was associated with shorter recurrence-free survival. A history of superficial tumors (p <0.01) and clinical stage (p = 0.01) was associated with advanced recurrence-free survival. The use of adjuvant chemotherapy (HR 0.18, p = 0.03) was associated with prolonged advanced recurrence-free survival, however adjuvant chemotherapy did not impact overall survival.
Conclusions: Partial cystectomy provides adequate local control of muscle invasive bladder cancer in select patients. Because late recurrence is not uncommon and is potentially life threatening, lifelong followup with cystoscopy is recommended.
Comment in
-
Bladder cancer: in search of the right operation for the right patient.J Urol. 2006 Jun;175(6):1987-8. doi: 10.1016/j.juro.2006.03.012. J Urol. 2006. PMID: 16697781 No abstract available.
Similar articles
-
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.J Urol. 2006 Aug;176(2):493-8; discussion 498-9. doi: 10.1016/j.juro.2006.03.065. J Urol. 2006. PMID: 16813876
-
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.J Urol. 2004 Sep;172(3):878-81. doi: 10.1097/01.ju.0000135530.59860.7d. J Urol. 2004. PMID: 15310988
-
Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.Urology. 2008 Sep;72(3):613-6. doi: 10.1016/j.urology.2008.04.052. Epub 2008 Jun 13. Urology. 2008. PMID: 18554696
-
[Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].Arch Esp Urol. 1996 May;49(4):349-64. Arch Esp Urol. 1996. PMID: 8754191 Review. Spanish.
-
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088. Urology. 2004. PMID: 15351577 Review.
Cited by
-
Survival Outcome of Partial Cystectomy versus Transurethral Bladder Tumor Resection in T1 High-Grade Bladder Cancer Patients: A Propensity Score Matching Study.J Oncol. 2022 Oct 25;2022:3016725. doi: 10.1155/2022/3016725. eCollection 2022. J Oncol. 2022. PMID: 36330353 Free PMC article.
-
Risk factors that impact long-term outcomes in sigmoid colon cancer with urinary bladder involvement.Langenbecks Arch Surg. 2023 Dec 29;409(1):22. doi: 10.1007/s00423-023-03204-9. Langenbecks Arch Surg. 2023. PMID: 38157060
-
Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?Urol Clin North Am. 2015 May;42(2):189-99, viii. doi: 10.1016/j.ucl.2015.02.003. Epub 2015 Feb 28. Urol Clin North Am. 2015. PMID: 25882561 Free PMC article. Review.
-
Contemporary management of muscle-invasive bladder cancer.Int J Clin Oncol. 2008 Dec;13(6):504-9. doi: 10.1007/s10147-008-0788-9. Epub 2008 Dec 18. Int J Clin Oncol. 2008. PMID: 19093177 Review.
-
Clinical outcomes of nephroureterectomy with bladder cuff excision or radical cystectomy for distal ureteral carcinoma invaded muscle of the ureteral orifice.BMC Cancer. 2025 Feb 7;25(1):221. doi: 10.1186/s12885-025-13646-7. BMC Cancer. 2025. PMID: 39920673 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical